Will hydroxyzine help manage withdrawal symptoms in a patient taking clonazepam and Ativan (lorazepam) who is at risk of withdrawal if Ativan (lorazepam) is stopped?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxyzine for Benzodiazepine Withdrawal Management

Hydroxyzine can be used as a supportive adjunctive medication during benzodiazepine withdrawal to help manage anxiety symptoms, but it should not replace a proper gradual taper protocol. 1, 2

Evidence for Hydroxyzine in Benzodiazepine Withdrawal

Direct Evidence from Withdrawal Studies

  • A controlled study of 154 patients withdrawing from long-term lorazepam (mean 64 months) demonstrated that hydroxyzine 50 mg significantly improved anxiety levels (p < 0.007), reduced withdrawal symptoms, and decreased side effects compared to placebo during the withdrawal period. 1

  • Hydroxyzine 25 mg also showed significant anxiety improvement (p < 0.012) during lorazepam withdrawal, though with less robust reduction in withdrawal symptoms than the 50 mg dose. 1

  • A Russian study of 59 patients on long-term benzodiazepines found that abrupt benzodiazepine discontinuation with hydroxyzine substitution resulted in only 23.3% dropout rate compared to 65.6% dropout with placebo, with greater anxiety reduction in the hydroxyzine group. 2

Dosing Recommendations Based on Evidence

  • For patients with marked anxiety during benzodiazepine withdrawal, hydroxyzine 25 mg can be prescribed as transient support. 1

  • For patients presenting with significant withdrawal symptomatology, hydroxyzine 50 mg is more appropriate and demonstrated superior reduction in withdrawal symptoms. 1

  • The most common side effect is daytime sleepiness, which occurs more frequently at the 50 mg dose. 1

Critical Framework: Hydroxyzine as Adjunct, Not Replacement

The Mandatory Gradual Taper Protocol

  • When discontinuing benzodiazepines (clonazepam and lorazepam), you must implement a gradual taper reducing by 10-25% of the current dose every 1-2 weeks—hydroxyzine serves only as symptomatic support during this process, not as a substitute for proper tapering. 3

  • Abrupt benzodiazepine discontinuation can cause seizures and death, making gradual tapering non-negotiable regardless of hydroxyzine use. 3

  • The taper rate must be determined by the patient's tolerance, not a rigid schedule, with pauses acceptable when withdrawal symptoms emerge. 3

Which Benzodiazepine to Taper First

  • When a patient is taking both clonazepam and lorazepam, taper the benzodiazepines first before addressing any other medications, as benzodiazepine withdrawal carries higher risks than opioid withdrawal. 3

  • If both benzodiazepines need adjustment, consider consolidating to a single long-acting agent (like clonazepam) before tapering, though this requires careful dose equivalency calculation. 3

Practical Implementation Algorithm

Step 1: Assess and Prepare

  • Check prescription drug monitoring program to identify all controlled substances. 3
  • Assess for history of withdrawal seizures, psychiatric comorbidities, and concurrent substance use disorders. 3
  • If history of withdrawal seizures exists, refer to specialist immediately—do not attempt office-based taper. 3

Step 2: Initiate Taper with Hydroxyzine Support

  • Begin reducing benzodiazepine by 10-25% of current dose every 1-2 weeks. 3
  • Simultaneously start hydroxyzine 25-50 mg based on anxiety severity and withdrawal symptom intensity. 1
  • For marked anxiety: hydroxyzine 25 mg. 1
  • For significant withdrawal symptoms: hydroxyzine 50 mg. 1

Step 3: Monitor and Adjust

  • Follow up at least monthly, with more frequent contact during difficult phases. 3
  • Monitor for withdrawal symptoms: anxiety, tremor, insomnia, sweating, tachycardia, seizures. 3
  • If withdrawal symptoms emerge, slow the taper rate further—do not increase hydroxyzine as compensation for too-rapid tapering. 3

Step 4: Duration and Expectations

  • The taper will require minimum 6-12 months, possibly longer—hydroxyzine is used transiently during this period, not as long-term maintenance. 3, 1
  • After successful benzodiazepine discontinuation, hydroxyzine can be discontinued as anxiety typically improves (75% of patients in one study were drug-free with decreased anxiety at 3 months post-withdrawal). 1

Additional Supportive Measures

Cognitive Behavioral Therapy

  • Integrating CBT during the taper significantly increases success rates and should be strongly recommended alongside hydroxyzine. 3

Other Pharmacological Adjuncts

  • Gabapentin (100-300 mg titrated upward) can help mitigate withdrawal symptoms. 3
  • Trazodone 25-200 mg for insomnia management without abuse potential. 3
  • Carbamazepine or pregabalin may assist discontinuation. 3

Critical Pitfalls to Avoid

  • Never use hydroxyzine as justification for rapid or abrupt benzodiazepine discontinuation—the taper must remain gradual regardless of adjunctive medications. 3, 1
  • Do not substitute another benzodiazepine or Z-drug (zolpidem) thinking it's safer—these carry similar risks. 3
  • Never abandon the patient if tapering is difficult; maintain therapeutic relationship and consider slower taper or temporary pause. 3
  • Warn patients about daytime sleepiness with hydroxyzine, particularly at 50 mg dose. 1

Comparative Context: Hydroxyzine vs. Benzodiazepines

  • Hydroxyzine preserves memory and attention while providing anxiolytic effects, unlike benzodiazepines which cause clear memory deficiencies. 4
  • Hydroxyzine lacks dependency potential and organ toxicity, making it appropriate for transitional support. 5
  • However, hydroxyzine's efficacy for generalized anxiety is less robust than benzodiazepines, which is why it serves as adjunctive support rather than primary treatment. 6

References

Research

[Use of anxiolytic atarax as a substitutive drug for benzodiazepine tranquilizers].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Recent clinical trials of hydroxyzine in generalized anxiety disorder.

Acta psychiatrica Scandinavica. Supplementum, 1998

Research

Hydroxyzine for generalised anxiety disorder.

The Cochrane database of systematic reviews, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.